Thalidomide in Combination With Temodar in Patients With Neuroendocrine Tumors

Clinical trial NCT00165230 · COMPLETED

Trial details

NCT number: NCT00165230
Sponsor: Dana-Farber Cancer Institute
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Neuroendocrine Tumor

Start date: 2002-05-01
Primary completion: 2006-07-01
Enrollment: 32

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.